跳至主要内容
临床试验/NCT04645979
NCT04645979已完成不适用

The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use

Bayer1 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2020年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
153
试验地点
1
主要终点
Experience with betamethasone plus loratadine via an online questionnaire

研究概览

简要总结

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
  • Participants allowing to use the data for research and marketing purposes as well as talking to authorities
  • Participants allowing us to use the pseudo-randomized individual data for further data analysis
  • Able to read and understand the language of the online questionnaire

排除标准

  • 未提供

结局指标

主要结局

Experience with betamethasone plus loratadine via an online questionnaire

时间窗: 2 months

Participants' experiences with betamethasone plus loratadine used under real life conditions.

次要结局

未报告次要终点

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study to Learn What Participants Think of... | 临床试验